[Pe-021] 一般演題ポスターセッション（英語）021

[Pe-021-3] Efficacy and Safety of Inebilizumab as Treatment for Newly Presenting NMOSD [Encore Presentation]

She Dewei¹, Lindsey John W.², Bernitsas Evanthia³, Komorita Naruyasu⁴, Cree Bruce A C.⁵ (1.Horizon Therapeutics, 2.Division of Multiple Sclerosis and Neuroimmunology, University of Texas Health Science Center at Houston, 3.Multiple Sclerosis Center, Wayne State School of Medicine, 4.Mitsubishi Tanabe Pharma Corporation, 5.UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco)